Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · IEX Real-Time Price · USD
8.89
+0.33 (3.86%)
At close: May 17, 2024, 4:00 PM
8.90
+0.01 (0.11%)
After-hours: May 17, 2024, 6:12 PM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $273.26 million as of May 17, 2024. Its market cap has decreased by -8.30% in one year.
Market Cap
273.26M
Enterprise Value
167.31M
1-Year Change
-8.30%
Ranking
Category
Stock Price
$8.89
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has increased from $235.12M to $273.26M, an increase of 16.22%. That is a compound annual growth rate of 10.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 274.50M | 3.86% |
| May 16, 2024 | 264.30M | -1.05% |
| May 15, 2024 | 267.10M | 3.49% |
| May 14, 2024 | 258.10M | 34.43% |
| May 13, 2024 | 192.00M | -3.27% |
| May 10, 2024 | 198.50M | 7.70% |
| May 9, 2024 | 184.30M | -1.07% |
| May 8, 2024 | 186.30M | -1.32% |
| May 7, 2024 | 188.80M | -5.55% |
| May 6, 2024 | 199.90M | -7.92% |
| May 3, 2024 | 217.10M | 13.37% |
| May 2, 2024 | 191.50M | 2.79% |
| May 1, 2024 | 186.30M | -9.48% |
| Apr 30, 2024 | 205.80M | -9.10% |
| Apr 29, 2024 | 226.40M | 18.22% |
| Apr 26, 2024 | 191.50M | -0.10% |
| Apr 25, 2024 | 191.70M | -10.88% |
| Apr 24, 2024 | 215.10M | -3.24% |
| Apr 23, 2024 | 222.30M | 3.25% |
| Apr 22, 2024 | 215.30M | 1.27% |
| Apr 19, 2024 | 212.60M | -10.90% |
| Apr 18, 2024 | 238.60M | 1.92% |
| Apr 17, 2024 | 234.10M | 9.19% |
| Apr 16, 2024 | 214.40M | -1.43% |
| Apr 15, 2024 | 217.50M | -3.80% |
View and export this data all the way back to 2022.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sight Sciences | 276.15M |
| Sharecare | 275.47M |
| ESSA Pharma | 274.28M |
| ChromaDex | 274.21M |
| Viemed Healthcare | 268.64M |
| Sera Prognostics | 267.00M |
| Monte Rosa Therapeutics | 264.18M |
| Quantum-Si incorporated | 263.78M |